Related Experiment Video
Updated: Jul 8, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.7K
Increase in Scabies Cases and Permethrin Nonresponse in Türkiye
Selahattin Aydemir1, Zübeyde Kul2, Fethi Barlik3
1Research Assistant, Department of Parasitology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Türkiye.
Indian Journal of Public Health
|April 11, 2025
Summary
Scabies cases surged in Türkiye, with increased recurrence after permethrin treatment during and post-COVID-19. Ivermectin proved effective for resistant cases, suggesting potential permethrin resistance.
Area of Science:
- Dermatology
- Epidemiology
- Infectious Diseases
Background:
- Scabies cases in Türkiye have reached epidemic proportions.
- The COVID-19 pandemic may have influenced scabies incidence and treatment outcomes.
Purpose of the Study:
- To evaluate scabies prevalence and treatment efficacy before, during, and after the COVID-19 pandemic.
- To compare scabies recurrence rates following permethrin treatment across different pandemic phases.
Main Methods:
- Retrospective analysis of patient data from Van İpekyolu 1st Family Health Center.
- Evaluation of demographic data and treatment methods for scabies diagnoses.
- Statistical analysis using the two proportions Z-test and Fisher's exact test.
Main Results:
- Scabies diagnoses increased significantly during the pandemic period.
- Recurrence rates after permethrin treatment were higher post-pandemic (31.1%) compared to pre-pandemic (17.9%).
- Ivermectin effectively treated patients who did not respond to permethrin.
Conclusions:
- A rise in scabies cases correlates with the COVID-19 pandemic.
- Increased permethrin treatment failures suggest potential resistance, necessitating alternative therapeutic strategies like ivermectin.
